See more : Banco Bilbao Vizcaya Argentaria, S.A. (BBVA.MC) Income Statement Analysis – Financial Results
Complete financial analysis of Integrative Health Technologies, Inc. (IHTI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Integrative Health Technologies, Inc., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Cassava Sciences, Inc. (SAVA) Income Statement Analysis – Financial Results
- Amwaj International Company (9537.SR) Income Statement Analysis – Financial Results
- American Leisure Holdings, Inc. (AMLH) Income Statement Analysis – Financial Results
- Neoenergia S.A. (NEOE3.SA) Income Statement Analysis – Financial Results
- Secoo Holding Limited (SECO) Income Statement Analysis – Financial Results
Integrative Health Technologies, Inc. (IHTI)
About Integrative Health Technologies, Inc.
Integrative Health Technologies, Inc. provides fee-based clinical trials, research and development, and consulting and testing services to the healthcare and nutritional industries. The company maintains a database that contains more than 30,000 tests and dates back more than 20 years which tracks the footprints of diseases. It also operates mobile and stationary dual energy x-ray absorptiometry (DEXA) body composition scanning units for measuring total body and regional bone densities, and body fat and lean mass. In addition, the company provides blood chemistry testing report that provides 43 chemistries, including HDL, LDL, C-reactive protein, thyroid, electrolytes, red and white blood cell counts, and glucose, etc. Integrative Health Technologies, Inc. was founded in 1999 and is based in San Antonio, Texas.
| Metric | 2009 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|
| Revenue | 447.50K | 14.87K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 369.93K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 77.57K | 14.87K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 17.33% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 38.88K | 52.06K | 55.17K | 2.54M | 538.64K | 17.00K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 38.88K | 52.06K | 55.17K | 2.54M | 538.64K | 17.00K |
| Cost & Expenses | 408.81K | 52.06K | 55.17K | 2.54M | 538.64K | 17.00K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 0.00 | -74.37K | -110.34K | 19.89K | 1.03K | 1.30K |
| EBITDA | 38.69K | -37.19K | -55.17K | -2.82M | -455.61K | -16.71K |
| EBITDA Ratio | 8.65% | -250.05% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 38.69K | 37.19K | 55.17K | 2.54M | 538.64K | 17.00K |
| Operating Income Ratio | 8.65% | 250.05% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 37.19K | 0.00 | 0.00 | -109.00K | -1.01K |
| Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | 429.64K | 15.99K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -38.69K | 74.37K | 110.34K | 0.00 | 0.00 | 1.01K |
| Net Income | 38.69K | -37.19K | -55.17K | -2.54M | -647.64K | -18.01K |
| Net Income Ratio | 8.65% | -250.05% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | -0.05 | -0.07 | -4.89 | -9.15 | -0.25 |
| EPS Diluted | 0.00 | -0.05 | -0.07 | -4.89 | -9.15 | -0.25 |
| Weighted Avg Shares Out | 0.00 | 723.68K | 751.75K | 518.58K | 70.78K | 72.07K |
| Weighted Avg Shares Out (Dil) | 0.00 | 723.68K | 751.75K | 518.58K | 70.78K | 72.07K |
Source: https://incomestatements.info
Category: Stock Reports